Biological E gets the World Health Organisation (WHO) approval to be an additional facility for production of Johnson & Johnson COVID-19 vaccine.
The Johnson & Johnson COVID-19 vaccine consists of a replication-incompetent recombinant adenovirus type 26 (Ad26) viral vector expressing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in a stabilized conformation.
- Read more about Biological E gets WHO nod for JnJ COVID vaccine production
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/biological-e-gets-who-nod-for-jnj-covid-vaccine-production
No comments:
Post a Comment